Back

Machine learning-based all-cause mortality risk assessment integrating novel biomarkers in patients with suspected or known coronary artery disease: the AI-ANOX-EXCEED-J Study

29 August 2026 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Predicting cardio-renal-metabolic disease (1) Biomarkers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Hiromichi Wada

NHO Kyoto Medical Centre, Kyoto (Japan)

6 More presentations in this session

Presentation thumbnail
Serum Let-7b and AKT3 predict cardiovascular death in type 2 diabetes: insights from miRNA profiling and target prediction
Miss H. Evirgen (Ankara, TR)
Abstract
Presentation thumbnail
Combined assessment of stress hyperglycemia ratio and hemoglobin glycation index to predict mortality after coronary revascularisation: a machine learning study
Miss L. Runqian (CN)
Abstract
Presentation thumbnail
Relationship between atherosclerotic burden and subclinical cardiac dysfunction in Type 2 Diabetes
Doctor T. Jinadu (Leicester, GB)
Abstract
Presentation thumbnail
Fourteen-year risk of MACE stratified by NT-proBNP and inflammatory biomarkers in type 2 diabetes
Doctor H. Bahrami (Herlev, DK)
Abstract
Presentation thumbnail
Integrating genetic, clinical, and behavioural factors may improve the prediction of type 2 diabetes
Doctor F. Escorcio Silva (Funchal, PT)
Abstract

Access the full session

Session thumbnail
Predicting cardio-renal-metabolic disease (1)

The Event

Event poster

ESC Congress 2026

29 August 2026 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Deep learning for mortality prediction in patients with a de-novo or worsened heart failure
29 August 2021
thumbnail
Congress Presentation
Involvement of growth differentiation factor 15 in paradoxical relationship between body mass index and mortality in patients with suspected or known coronary artery disease; The ANOX Study
29 August 2022
thumbnail
Congress Presentation
Prognostic value of vascular inflammation biomarkers over clinical risk factors for cardiovascular risk : a meta-analysis
17 April 2021
thumbnail
Congress Presentation
Lymphangiogenic factors and all-cause and cause-specific mortality and impact of chronic kidney disease on them in patients with suspected or known coronary artery disease: The EXCEED-J Study
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources